Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Giuseppe Tauriello

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

September 23, 2024
Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.
Read Transcript

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype drummed up by tech executives and venture capitalists around the emerging technology.

Tech companies leveraged to the AI boom have surged in the last couple of years, with investor groups ranging from the most sophisticated institutions to mum and dad investors pouring money in amid fears of missing out on the tech revolution.

AI poster child Nvidia’s share price has more than doubled this year alone, lifting the chip-maker's value to around $US2.8 trillion ($4.12 trillion), making it the third largest publicly traded company in the world after Apple and Microsoft.

Other tech giants, including Microsoft, Meta and Google owner Alphabet, are also riding the wave of investor demand, with double-digit share price growth since the start of the year.

While many analysts believe there is more growth to come, Gautam, who will be among the headline speakers at November’s Sohn Hearts & Minds investment conference in Adelaide, is more bearish about the ballooning valuations that have some fearing are a bubble waiting to burst.

“I would like to stay away from the word (bubble) but I would say that the pace of expectations and the amount of mind-share that AI has received in the last 18 months – it appears parabolic and capitalism does not like parabolic moves,” he says.

“I think AI is a theme, and everybody’s looking to invest in that theme. Our experience over the last decade-plus, both in the public market but before that private equity, is that investing in themes is usually not a good idea, because the way the fundamentals play out is very different than what you were investing in.

“Our experience always says that you want to invest in bottom-up evaluation of a company, and maybe the theme might help or might not help. We’re not trying to be predicting the future in any ways, but what we’re saying is that you’re better off taking things slow and letting it materialise with a relatively natural rate of growth, versus starting to have exponential growth, because exponential growth inevitably leads to crashes.”

After starting his career as a management consultant at McKinsey & Co, Gautam later worked at a tech start-up in Silicon Valley before moving into private equity at Bain and Audax Group, and later developed his tech investment specialisation while at $US1.3bn hedge fund Hirzel Capital.

In 2017 he launched Dallas-based Scalar Gauge Fund, a specialist platform that adopts a “private equity style of investing” to its holdings of predominantly US-listed software companies.

The fund has grown to around $US200m in assets under management, including a mix of passive investments and other companies where Gautam sees an opportunity to add value.

Described by some as an activist investor, Gautam prefers to focus on the “value creation” that comes with a more hands-on approach, including working closely with management to drive performance and at times pushing for board representation, as it recently has with billing software company Zuora.

“The way we think about this is as long as we are creating value, then the shareholders or the stakeholders will benefit from that value creation,” he says.

“We are focused on investing in undervalued, higher quality software companies in the public markets, but then we sometimes play a constructivist role in adding value to these companies, either just working with management, but also sometimes bringing in private equity to acquire these companies.

“So the claim to fame that we’ve had in the last seven years has been that 34 of our portfolio companies have been acquired, most of them by private equity.

“And 34 may not sound like a big number, but there’s only been about 60 public-to-private deals that have happened in this time frame in the space that we play in, in technology, so market share is more than 50 per cent.”

Indian-born Gautam studied engineering at the Indian Institute of Technology before moving to the US in the late 1990s for further studies at MIT.

He will not be drawn on his preferred candidate for the election in his adopted homeland, but says the US needs “more economic growth and we need to embrace more capitalism”.

While clearly a free marketeer, Gautam holds some concern over the rising power of the so-called Magnificent Seven tech giants.

Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta and Tesla make up around a third of the S&P 500 index, and Scalar Gauge analysis suggests that based on growth rates over the past eight years the share they could reach two-thirds within the next ­decade. “Just by the nature of that power concentration, we don’t believe that society or the laws of economics will let that happen, because it’s just not a healthy place to be,” he said.

“If that’s not the case, which means that the historical returns are not going to be the same as future returns – if you believe that assertion, then you have to look elsewhere. The capitalistic way of thinking about it is that you’ll get new companies to challenge. There’s definitely a regulation aspect to it as well.

“In general, we like government to not be involved in the markets, because it’s generally inefficient. But we also can understand the reasons, that it has impact on society, impact on free speech – these companies have become a lot more influential.

“We have nothing against these companies. And they, of course, have done phenomenally well. But we don’t believe it’s healthy on a society, or on the information dissemination viewpoint, or from just the concentration of power in just one entity.”

Gautam will be among the headline speakers at this year’s Sohn event, which has raised $70m for medical research since its launch in 2016.

Attendees will hear stock tips and investment strategies from some of the world’s top fund managers, including Oaktree Capital co-founder Howard Marks, Sydney fund manager Alex Pollak, the founder of Loftus Peak, and Terra Capital founder and chief investment officer Jeremy Bond.

The Sohn Hearts & Minds conference will be held at Adelaide’s Festival Theatre on November 15.

This article was originally posted by The Australian here. 

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 23 September 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype drummed up by tech executives and venture capitalists around the emerging technology.

Tech companies leveraged to the AI boom have surged in the last couple of years, with investor groups ranging from the most sophisticated institutions to mum and dad investors pouring money in amid fears of missing out on the tech revolution.

AI poster child Nvidia’s share price has more than doubled this year alone, lifting the chip-maker's value to around $US2.8 trillion ($4.12 trillion), making it the third largest publicly traded company in the world after Apple and Microsoft.

Other tech giants, including Microsoft, Meta and Google owner Alphabet, are also riding the wave of investor demand, with double-digit share price growth since the start of the year.

While many analysts believe there is more growth to come, Gautam, who will be among the headline speakers at November’s Sohn Hearts & Minds investment conference in Adelaide, is more bearish about the ballooning valuations that have some fearing are a bubble waiting to burst.

“I would like to stay away from the word (bubble) but I would say that the pace of expectations and the amount of mind-share that AI has received in the last 18 months – it appears parabolic and capitalism does not like parabolic moves,” he says.

“I think AI is a theme, and everybody’s looking to invest in that theme. Our experience over the last decade-plus, both in the public market but before that private equity, is that investing in themes is usually not a good idea, because the way the fundamentals play out is very different than what you were investing in.

“Our experience always says that you want to invest in bottom-up evaluation of a company, and maybe the theme might help or might not help. We’re not trying to be predicting the future in any ways, but what we’re saying is that you’re better off taking things slow and letting it materialise with a relatively natural rate of growth, versus starting to have exponential growth, because exponential growth inevitably leads to crashes.”

After starting his career as a management consultant at McKinsey & Co, Gautam later worked at a tech start-up in Silicon Valley before moving into private equity at Bain and Audax Group, and later developed his tech investment specialisation while at $US1.3bn hedge fund Hirzel Capital.

In 2017 he launched Dallas-based Scalar Gauge Fund, a specialist platform that adopts a “private equity style of investing” to its holdings of predominantly US-listed software companies.

The fund has grown to around $US200m in assets under management, including a mix of passive investments and other companies where Gautam sees an opportunity to add value.

Described by some as an activist investor, Gautam prefers to focus on the “value creation” that comes with a more hands-on approach, including working closely with management to drive performance and at times pushing for board representation, as it recently has with billing software company Zuora.

“The way we think about this is as long as we are creating value, then the shareholders or the stakeholders will benefit from that value creation,” he says.

“We are focused on investing in undervalued, higher quality software companies in the public markets, but then we sometimes play a constructivist role in adding value to these companies, either just working with management, but also sometimes bringing in private equity to acquire these companies.

“So the claim to fame that we’ve had in the last seven years has been that 34 of our portfolio companies have been acquired, most of them by private equity.

“And 34 may not sound like a big number, but there’s only been about 60 public-to-private deals that have happened in this time frame in the space that we play in, in technology, so market share is more than 50 per cent.”

Indian-born Gautam studied engineering at the Indian Institute of Technology before moving to the US in the late 1990s for further studies at MIT.

He will not be drawn on his preferred candidate for the election in his adopted homeland, but says the US needs “more economic growth and we need to embrace more capitalism”.

While clearly a free marketeer, Gautam holds some concern over the rising power of the so-called Magnificent Seven tech giants.

Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta and Tesla make up around a third of the S&P 500 index, and Scalar Gauge analysis suggests that based on growth rates over the past eight years the share they could reach two-thirds within the next ­decade. “Just by the nature of that power concentration, we don’t believe that society or the laws of economics will let that happen, because it’s just not a healthy place to be,” he said.

“If that’s not the case, which means that the historical returns are not going to be the same as future returns – if you believe that assertion, then you have to look elsewhere. The capitalistic way of thinking about it is that you’ll get new companies to challenge. There’s definitely a regulation aspect to it as well.

“In general, we like government to not be involved in the markets, because it’s generally inefficient. But we also can understand the reasons, that it has impact on society, impact on free speech – these companies have become a lot more influential.

“We have nothing against these companies. And they, of course, have done phenomenally well. But we don’t believe it’s healthy on a society, or on the information dissemination viewpoint, or from just the concentration of power in just one entity.”

Gautam will be among the headline speakers at this year’s Sohn event, which has raised $70m for medical research since its launch in 2016.

Attendees will hear stock tips and investment strategies from some of the world’s top fund managers, including Oaktree Capital co-founder Howard Marks, Sydney fund manager Alex Pollak, the founder of Loftus Peak, and Terra Capital founder and chief investment officer Jeremy Bond.

The Sohn Hearts & Minds conference will be held at Adelaide’s Festival Theatre on November 15.

This article was originally posted by The Australian here. 

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 23 September 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by The Australian, published on Sep 23, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
March 14, 2025

$1.4 million boost for SA medical research

South Australian medical research will receive a $1.4 million cash injection, as a direct result of a major investment and philanthropy conference held in Adelaide.

Read More
Anthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. AP
May 19, 2025

Why ‘The Mooch’ thinks Trump is more dangerous this time around

Anthony Scaramucci says Trump has fewer constraints on his worst instincts in his second administration. But he still gets bored easily.

Read More
Image caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn Licht
May 19, 2025

My biggest mistake: Anthony Scaramucci on what makes Donald Trump tick

On Elon Musk, money and the White House, fast-talking Wall Street hedge fund manager and former Trump communications director Anthony Scaramucci tells it as he sees it.

Read More
A bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFP
May 19, 2025

Bitcoin ‘on track’ for $US200,000: Anthony Scaramucci

Bitcoin could hit as much as $US200,000 ($311,000) by the end of this year, fuelled by surging inflows into exchange-traded funds and Donald Trump’s erratic policymaking.

Read More
Anthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn Licht
May 19, 2025

‘The Mooch’ says Trump will have to cut China tariffs below 10pc

Scaramucci, who is best known as The Mooch, is the first big-name global investor to be confirmed for the Sohn Hearts & Minds conference in Sydney in November.

Read More
December 19, 2024

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
Nick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben SearcyNick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben Searcy
November 20, 2024

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
Wall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben Searcy
November 17, 2024

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
Ellerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy Photography
November 15, 2024

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
November 15, 2024

Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

Read More
November 15, 2024

Sohn ASX stock pick: Ellerston Capital’s Chris Kourtis backs Perpetual

Chris Kourtis has put his biggest bet on embattled Perpetual – picking one of the most hated stocks on the ASX – that he believes will soon be the ‘cheapest listed asset manager of scale in the universe’.

Read More
Markets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFPMarkets will have to adjust to a world in which a new Donald Trump presidency will continue to ‘bash’ Xi Jinping’s China. Picture: AFP
November 15, 2024

Sohn investors position for bullish but bumpy Trump ride

Australia and the rest of the world must adjust to a new Trump presidency that will deliver an expected bull market but also disruption, with the leader in waiting prepared to “create pain” to get his way.

Read More
November 15, 2024

Sohn stock picker experts name best shares to invest in for year ahead

‍Don’t overlook down and out silver miners, legacy skincare brands ready for a revival and a big financial company suffering from a severe case of shareholder wealth destruction.

Read More
November 15, 2024

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

Read More
Mike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/Bloomberg
November 9, 2024

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.